Suppr超能文献

一项对七个发展中国家痴呆患病率的系统评价和荟萃分析:STRiDE 项目。

A systematic review and meta-analysis of dementia prevalence in seven developing countries: A STRiDE project.

机构信息

Centre for Dementia Studies, Brighton and Sussex Medical School, Brighton, UK.

Faculty of Biomedical Sciences, Università della Svizzera italiana, Lugano, Switzerland.

出版信息

Glob Public Health. 2020 Dec;15(12):1878-1893. doi: 10.1080/17441692.2020.1792527. Epub 2020 Jul 13.

Abstract

The STRiDE project sets out to support the development of effective dementia policy in middle-income countries (Brazil, India, Indonesia, Jamaica, Kenya, Mexico, and South Africa). As part of this it will generate new data about the prevalence of dementia for a subset of these countries. This study aims to identify the current estimates of dementia prevalence in these countries and where the gaps lie in the current literature. A systematic review was completed on 30th April 2019 across electronic databases, identifying dementia prevalence literature originating from any of the seven countries. Four hundred and twenty-nine records were identified following de-duplication; 28 studies met the inclusion criteria and were included in the systematic review. Pooled estimates of dementia prevalence ranged from 2% to 9% based on DSM-IV criteria; these figures were generally higher in studies using other diagnostic criteria (e.g. the 10/66 algorithm). Available prevalence data varied between countries. Only Brazil, Mexico and India had data derived from studies judged as having a low risk of bias. Irrespective of country, studies often were not explicit in detailing the representativeness of their sample, or whether there was non-response bias. Further transparent and externally valid dementia prevalence research is needed across the STRiDE countries.

摘要

STRiDE 项目旨在支持中等收入国家(巴西、印度、印度尼西亚、牙买加、肯尼亚、墨西哥和南非)制定有效的痴呆症政策。作为其中的一部分,它将为其中一些国家生成有关痴呆症患病率的新数据。本研究旨在确定这些国家目前的痴呆症患病率估计数,并确定当前文献中的差距所在。2019 年 4 月 30 日,我们在电子数据库中完成了一项系统评价,确定了源自这七个国家的任何一个的痴呆症患病率文献。在去重后,共确定了 429 份记录;有 28 项研究符合纳入标准并纳入了系统评价。根据 DSM-IV 标准,痴呆症患病率的汇总估计值范围为 2%至 9%;使用其他诊断标准(例如 10/66 算法)的研究中,这些数字通常更高。可用的患病率数据在各国之间存在差异。只有巴西、墨西哥和印度有源自被认为具有低偏倚风险的研究的数据。无论国家如何,研究往往没有明确详细说明其样本的代表性,或者是否存在无应答偏差。STRiDE 国家需要进一步开展透明且具有外部有效性的痴呆症患病率研究。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验